2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
| 热门AI工具： |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | EUROPEAN UROLOGY EUR UROL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.4
52人评分
我要评分
声誉 9.9 影响力 9.4 速度 7.1 | |||||||||||||||||
| 期刊ISSN | 0302-2838 | 安装APP，查看期刊最新消息
| ||||||||||||||||
| E-ISSN | 1421-993X | |||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||
| 实时影响因子 | 截止2026年9月20日：24.567 | |||||||||||||||||
| 2025-2026自引率 | 2.7%点击查看自引率趋势图 | |||||||||||||||||
| 五年IF （数据来源于网友提供） | 24.999数据由网友[佛系钢琴]收集提供 | |||||||||||||||||
| h-index | 187 | |||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||
| 期刊简介 |
| |||||||||||||||||
| 期刊官方网站 | http://www.europeanurology.com/ | |||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/EURUROL | |||||||||||||||||
| 该期刊中国学者近期发文 - New | Re: Bacillus Calmette-Guerin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guerin-naïve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301) Author: Li, Daoyuan Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 176-176. DOI: 10.1016/j.eururo.2026.03.011 Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial Author: Yao, Yuntao; Liu, Yifan; Li, Yuanan; Lu, Bingnan; Cui, Xingang; Pan, Xiuwu Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 182-183. DOI: 10.1016/j.eururo.2026.04.003 Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 Trial Author: Tikkinen, Kari A. O.; Marcucci, Maura; Halme, Alex L. E.; Ofori, Sandra N.; Borges, Flavia K.; Kanstrup, Charlotte T. B.; Park, Lily J.; Tondroanamag, Farhad; Kilpelainen, Tuomas P.; Tornberg, Sara, V; Painter, Thomas W.; Conen, David; Lomivorotov, Vladimir; Sessler, Daniel I.; Chan, Matthew T. V.; Martinez-Zapata, Maria Jose; Wang, Chew Y.; Xavier, Denis B.; Wang, Michael K.; Szczeklik, Wojciech; Leslie, Kate; Lavallee, Luke T.; Breau, Rodney H.; Balasubramanian, Kumar; Devereaux, P. J Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 140-149. DOI: 10.1016/j.eururo.2026.03.019 Re: Ipilimumab and Nivolumab Followed by Chemoradiotherapy as Bladder-sparing Treatment in Muscle-invasive Bladder Cancer: A Phase 2 Trial Author: Lu, Wenlong; Chen, Lin Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 181-182. DOI: 10.1016/j.eururo.2026.04.002 | |||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足EUROPEAN UROLOGY的语言要求，还能让EUROPEAN UROLOGY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被EUROPEAN UROLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||
| 通讯方式 | ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE | |||||||||||||||||
| 出版商 | Elsevier | |||||||||||||||||
| 涉及的研究方向 | 医学-泌尿学与肾脏学 | |||||||||||||||||
| 出版国家或地区 | NETHERLANDS | |||||||||||||||||
| 出版语言 | English | |||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||
| 出版年份 | 1975 | |||||||||||||||||
| 年文章数 | 87点击查看年文章数趋势图 | |||||||||||||||||
| Gold OA文章占比 | 41.24% | |||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 77.01% | |||||||||||||||||
| WOS期刊JCR分区 （ 2025-2026年最新版） | 注册或登录后，查看WOS分区等级 | |||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||
  | ||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0302-2838%5BISSN%5D | |||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-6周 来源Elsevier官网： 平均3周 | |||||||||||||||||
| 平均录用比例 | 网友分享经验： 很难 | |||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在EUROPEAN UROLOGY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均21.8周 | |||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Re: Bacillus Calmette-Guerin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guerin-naïve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301) Author: Li, Daoyuan Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 176-176. DOI: 10.1016/j.eururo.2026.03.011 PubMed DOI |
| 2. | Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial Author: Yao, Yuntao; Liu, Yifan; Li, Yuanan; Lu, Bingnan; Cui, Xingang; Pan, Xiuwu Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 182-183. DOI: 10.1016/j.eururo.2026.04.003 PubMed DOI |
| 3. | Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 Trial Author: Tikkinen, Kari A. O.; Marcucci, Maura; Halme, Alex L. E.; Ofori, Sandra N.; Borges, Flavia K.; Kanstrup, Charlotte T. B.; Park, Lily J.; Tondroanamag, Farhad; Kilpelainen, Tuomas P.; Tornberg, Sara, V; Painter, Thomas W.; Conen, David; Lomivorotov, Vladimir; Sessler, Daniel I.; Chan, Matthew T. V.; Martinez-Zapata, Maria Jose; Wang, Chew Y.; Xavier, Denis B.; Wang, Michael K.; Szczeklik, Wojciech; Leslie, Kate; Lavallee, Luke T.; Breau, Rodney H.; Balasubramanian, Kumar; Devereaux, P. J Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 140-149. DOI: 10.1016/j.eururo.2026.03.019 PubMed DOI |
| 4. | Re: Ipilimumab and Nivolumab Followed by Chemoradiotherapy as Bladder-sparing Treatment in Muscle-invasive Bladder Cancer: A Phase 2 Trial Author: Lu, Wenlong; Chen, Lin Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 181-182. DOI: 10.1016/j.eururo.2026.04.002 PubMed DOI |
| 5. | Re: Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial Author: Zhou, Jumei; Liu, Ping Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 180-181. DOI: 10.1016/j.eururo.2026.03.017 PubMed DOI |
| 6. | Efficacy and Safety of Disitamab Vedotin Combined with Gemcitabine as Neoadjuvant Therapy in Muscle-invas ive Bladder Cancer: An Open-label, Multicenter, Single-arm, Phase 2 Trial Author: Huang, Haijun; Ma, Wei; Zeng, Xing; Liu, Bo; Dai, Haitao; Zhou, Gaofeng; Wan, Jie; Zhang, Yucong; Hu, Zhiquan; Yang, Chunguang Journal: EUROPEAN UROLOGY. 2026; Vol. 90, Issue 2, pp. 103-107. DOI: 10.1016/j.eururo.2025.10.009 PubMed DOI |
| 7. | Re: Nikhil Mayor, Alexander Light, Anna Silvanto, et al. IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy. Eur Urol. 2026;89: 223-232 Author: Tang, Gonglin; Zhao, Hongwei Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 6, pp. e142-e143. DOI: 10.1016/j.eururo.2025.10.026 PubMed DOI |
| 8. | Re: Disitamab Vedotin plus Toripalimab in HER2-expressing Advanced Urothelial Cancer Author: Liu, Ping; Chen, Jinbo; Zhou, Jumei Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 6, pp. 551-552. DOI: 10.1016/j.eururo.2026.01.020 PubMed DOI |
| 9. | Re: Soluble MAdCAM-1 as a Biomarker in Metastatic Renal Cell Carcinoma Author: Li, Yuanan; Liu, Yifan; Lu, Bingnan; Yao, Yuntao; Lyu, Donghao; Zhang, Hangbiao; Cui, Xingang; Pan, Xiuwu Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 6, pp. 556-557. DOI: 10.1016/j.eururo.2026.02.005 PubMed DOI |
| 10. | Development and Validation of a Novel Plasma Metabolomic Signature for the Detection of Renal Cell Carcinoma Author: Huang, Cong; Wang, Guangxi; Yuan, Yuyao; Zou, Yang; Tang, Xiaowei; Guo, Heng; Song, Huajie; Gao, Wenzhi; Wang, Aixiang; Yu, Yanfei; Tian, Ye; Chi, Chunhua; Dong, Aimei; Li, Haixia; Li, Xuesong; He, Shiming; Yin, Yuxin; Zhou, Liqun Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 6, pp. 521-531. DOI: 10.1016/j.eururo.2025.09.4148 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共28条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
